Expression of complement messenger RNAs and proteins by human oligodendroglial cells

GLIA

Volumn 42, Issue 4, 2003, Pages 417-423

  Hosokawa, Masato ^a   Klegeris, Andis ^a   Maguire, John ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease; Multiple sclerosis; Neurodegenerative diseases

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C1R; COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT COMPONENT C9; MESSENGER RNA; MYELIN; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CELL ISOLATION; DEGENERATIVE DISEASE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL; NERVOUS SYSTEM INFLAMMATION; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WHITE MATTER;

ADULT; BIOLOGICAL MARKERS; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0038458963     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10234     Document Type: Article

References (29)

1. Barnum SR. 1995. Complement biosynthesis in the central nervous system. Crit Rev Oral Biol Med 6:132-146.
2. Bronstein JM, Micevych PE, Chen K. 1997. Oligodendrocyte-specific protein (OSP) is a major component of CNS myelin. J Neurosci Res 50:713-720.
3. Compston DAS, Morgan BP, Campbell AK, Wilkins P, Cole G, Thomas ND, Jasani B. 1989. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol Appl Neurobiol 15:307-316.
4. De Groot CJA, Montagne L, Janssen I, Ravid R, Van Der Valk P, Veerhuis R. 2000. Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue. Brain Res Protocols 5:85-94.
5. Eikelenboom P, Hack CE, Rozemuller JM, Stam FC. 1989. Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch B Cell Pathol 56:259-262.
6. Gasque P, Ischenko A, Legoedec J, Mauger C, Schouft MT, Fontaine M. 1993. Expression of the complement classical pathway by human glioma in culture. J Biol Chem 268:25068-25074.
7. Groome N, Dawkes A, Barry R, Hruby S, Alvord E Jr. 1988. New monoclonal antibodies reactive with defined seqential epitopes in human myelin basic protein. J Neuroimmunol 19:305-315.
8. Ishii T, Ohsugi K, Nakamura S, Sato K, Hashimoto M, Mikoshiba K, Sakuragawa N. 1999. Gene expression of oligodendrocyte markers in human amniotic epithelial cells using neural cell-type-specific expression system. Neurosci Lett 268:131-134.
9. Klegeris A, Bissonnette CJ, Dorovini-Zis K, McGeer PL. 2000. Expression of complement messenger RNAs by human endothelial cells. Brain Res 871:1-6.
10. McGeer PL, Akiyama H, Itagaki S, McGeer EG. 1989. Immune system response in Alzheimer's disease. Can J Neurol Sci 16:516-527.
11. McGeer PL, McGeer EG. 1995. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21:195-218.
12. Morgan BP, Gasque P. 1996. Expression of complement in the brain: role in health and disease. Immunol Today 17:461-466.
13. Prineas JW, Kwon EE, Cho ES, Sharer LR, Barnett MH, Oleszak EL, Hoffman B, Morgan BP. 2001. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol 50:646-657.
14. Schachner M, Kim SK, Zehnle R. 1981. Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies. Dev Biol 83:328-338.
15. Schwab C, McGeer PL. 2002. Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis. Exp Neurol 174:81-88.
16. Scolding NJ, Morgan BP, Compston DAS. 1998. The expression of complement regulatory proteins by adult human oligodendrocytes. J Neuroimmunol 84:69-75.
17. Shen Y, Li R, McGeer EG, McGeer PL. 1997. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain. Brain Res 769:391-395.
18. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311-327.
19. Sprinkle TJ. 1989. 2′,3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4:235-301.
20. Terai K, Walker DG, McGeer EG, McGeer PL. 1997. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res 769:385-390.
21. Vastag M, Skopal J, Kramer J, Kolev K, Voko Z, Csonka E, Machovich R, Nagy Z. 1998. Endothelial cells cultured from human brain microvessels produce complement proteins factor H, factor B, C1 inhibitor, and C4. Immunobiology 199:5-13.
22. Verga L, Frangione B, Tagliavini F, Giaccone G, Migheli A, Bugiani O. 1989. Alzheimer patients and Down patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett 105:294-299.
23. Walker DG, Kim SU, McGeer PL. 1995. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 40:478-493.
24. Walker DG, Kim SU, McGeer PL. 1998. Expression of complement C4 and C9 genes by human astrocytes. Brain Res 809:31-38.
25. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J. 1997. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging 18:415-421.
26. Yamada T, Akiyama H, McGeer PL. 1990. Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d. Neurosci Lett 112:161-166.
27. Yamada T, McGeer PL, McGeer EG. 1991. Relationship of complement-activated oligodendrocytes to reactive microglia and neuronal pathology in neurodegenerative disease. Dementia 2:71-77.
28. Yashojima K, Schwab C, McGeer EG, McGeer PL. 1998. Human heart generates complement proteins that are upregulated and activated after myocardial infarction. Circ Res 83:860-869.
29. Yashojima K, Schwab C, McGeer EG, McGeer PL. 2000. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 887:80-89.